Publications by authors named "Neelu Puri"

Claim this Profile
T
The Role of Fat Mass and Obesity-Associated (FTO) Gene in Non-Small Cell Lung Cancer Tumorigenicity and EGFR Tyrosine Kinase Inhibitor Resistance.
Aayush Rastogi, Rong Qiu, Rachel Campoli, Usama Altayeh, Sarai Arriaga, Neelu Puri

Biomedicines· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Smoking on Telomere Length, Induction of Oncogenic Stress, and Chronic Inflammatory Responses Leading to Aging.
Shreya Deb, Joseph Berei, Edward Miliavski, Muhammad J Khan, Taylor J Broder, Neelu Puri

Cells· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRMT-1 and p120-Catenin as EMT Mediators in Osimertinib Resistance in NSCLC.
Kavya Sri Racherla, Katrina Dovalovsky, Meet Patel, Emma Harper, Jacob Barnard, Neelu Puri

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Metastatic Melanoma with a Combination of Immunotherapies and Molecularly Targeted Therapies.
Taylor Rager, Adam Eckburg, Meet Patel, Rong Qiu, Shahina Gantiwala, Neelu Puri

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediating EGFR-TKI Resistance by VEGF/VEGFR Autocrine Pathway in Non-Small Cell Lung Cancer.
Chike Osude, Leo Lin, Meet Patel, Adam Eckburg, Joseph Berei, Neelu Puri

Cells· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to Molecularly Targeted Therapies in Melanoma.
Meet Patel, Adam Eckburg, Shahina Gantiwala, Zachary Hart, Joshua Dein, Neelu Puri

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Telomere-Related Pharmacological Targets.
Joseph Berei, Adam Eckburg, Edward Miliavski, Austin D Anderson, Rachel J Miller, Neelu Puri

Curr Top Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer.
Zachary D Crees, Caleb Shearrow, Leo Lin, Jennifer Girard, Kavin Arasi, Neelu Puri

Ther Adv Med Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligonucleotides and microRNAs Targeting Telomerase Subunits in Cancer Therapy.
Adam Eckburg, Joshua Dein, Joseph Berei, Zachary Schrank, Neelu Puri

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligonucleotides Targeting Telomeres and Telomerase in Cancer.
Zachary Schrank, Nabiha Khan, Chike Osude, Sanjana Singh, Rachel J Miller, Neelu Puri

Molecules· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Molecular-Targeted Therapies in NSCLC and Their Mechanism of Resistance.
Zachary Schrank, Gagan Chhabra, Leo Lin, Tsatsral Iderzorig, Chike Osude, Neelu Puri

Cancers (Basel)· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of Action of G-Quadruplex-Forming Oligonucleotide Homologous to the Telomere Overhang in Melanoma.
Gagan Chhabra, Luke Wojdyla, Mark Frakes, Zachary Schrank, Brandon Leviskas, Neelu Puri

J Invest Dermatol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of EMT mediated tyrosine kinase inhibitor resistance in NSCLC.
Tsatsral Iderzorig, Joseph Kellen, Chike Osude, Sanjana Singh, James A Woodman, Neelu Puri

Biochem Biophys Res Commun· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating Cancer by Targeting Telomeres and Telomerase.
Marko Ivancich, Zachary Schrank, Luke Wojdyla, Brandon Leviskas, Adijan Kuckovic, Neelu Puri

Antioxidants (Basel)· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of c-Met and EGFR tyrosine kinase inhibitor resistance through epithelial mesenchymal transition in non-small cell lung cancer.
Ichwaku Rastogi, Supriya Rajanna, Andrew Webb, Gagan Chhabra, Brad Foster, Neelu Puri

Biochem Biophys Res Commun· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
Gregory M Botting, Ichwaku Rastogi, Gagan Chhabra, Marie Nlend, Neelu Puri

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Molecularly Targeting Therapies in NSCLC and Melanoma.
Supriya Rajanna, Ichwaku Rastogi, Luke Wojdyla, Hiroko Furo, Agnes Kulesza, Neelu Puri

Anticancer Agents Med Chem· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligonucleotides and G-quadruplex stabilizers: targeting telomeres and telomerase in cancer therapy.
Zachary Crees, Jennifer Girard, Zechary Rios, Gregory M Botting, Kymberly Harrington, Neelu Puri

Curr Pharm Des· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer.
Gagan Chhabra, Ashley Eggert, Neelu Puri

Arch Cancer Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting c-Met in melanoma: mechanism of resistance and efficacy of novel combinatorial inhibitor therapy.
Deven Etnyre, Amanda L Stone, Jason T Fong, Ryan J Jacobs, Srijayaprakash B Uppada, Neelu Puri

Cancer Biol Ther· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative signaling pathways as potential therapeutic targets for overcoming EGFR and c-Met inhibitor resistance in non-small cell lung cancer.
Jason T Fong, Ryan J Jacobs, David N Moravec, Srijayaprakash B Uppada, Gregory M Botting, Neelu Puri

PLoS One· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel delivery system for T-oligo using a nanocomplex formed with an alpha helical peptide for melanoma therapy.
Srijayaprakash B Uppada, Terrianne Erickson, Luke Wojdyla, David N Moravec, Ziyuan Song, Neelu Puri

Int J Nanomedicine· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-oligo as an anticancer agent in colorectal cancer.
Luke Wojdyla, Amanda L Stone, Nan Sethakorn, Srijayaprakash B Uppada, Joseph T Devito, Neelu Puri

Biochem Biophys Res Commun· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides.
Neelu Puri, Ryan T Pitman, Richard E Mulnix, Terrianne Erickson, Audra N Iness

Cancer Lett· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
hnRNP C1/C2 and Pur-beta proteins mediate induction of senescence by oligonucleotides homologous to the telomere overhang.
Richard E Mulnix, Ryan T Pitman, Allison Retzer, Ceyda Bertram, Kavin Arasi, Neelu Puri

Onco Targets Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis